Merck & Company Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Cash-and-Equivalents" stands at 18.17 Billion United States Dollars as of 09/30/2025, the highest value at least since 03/31/2011, the period currently displayed.
As of the end of Merck & Company Inc's third quarter, the item "Cash and Equivalents" stands at 18.17 Billion USD. This represents an increase of 126.91 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 24.50 percent compared to the value the year prior.
The 1 year change in percent is 24.50.
The 3 year change in percent is 63.02.
The 5 year change in percent is 147.00.
The 10 year change in percent is 140.71.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Cash and Equivalents | 905,699,262,464.00 |
![]() | Johnson & Johnson - Cash and Equivalents | 486,508,953,600.00 |
![]() | AbbVie Inc - Cash and Equivalents | 399,570,305,024.00 |
![]() | Roche Holding AG - Cash and Equivalents | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Cash and Equivalents | 280,205,508,085.11 |